1,721,069 research outputs found
Emerging F-18-Labelled PET Myocardial Perfusion Tracers
No full textPurpose of Review: PET myocardial perfusion imaging (MPI) is an established modality for the evaluation of ischemic heart disease and quantitation of myocardial blood flow (MBF). New F-18-labelled radiopharmaceuticals have been recently developed to overcome some of the limitations of currently used tracers such as the need of an on-site cyclotron. The characteristics of the new tracers and the clinical results obtained so far will be reviewed. Recent Findings: Most of the interest in the field of 18F-labelled radiotracers for PET MPI has been concentrated on MC-1 inhibitors, the prototype of which is 18F-flurpiridaz. It was shown in experimental and clinical reports that these radiotracers allow good quality rest/stress MPI studies and a reliable quantitation of MBF. Summary: Recent evidence suggests that PET MPI with 18F-flurpiridaz may provide a superior diagnostic accuracy for obstructive CAD even if a large comparative clinical trial with SPECT is still ongoing
Imaging the heart’s brain: Simultaneous innervation/perfusion analysis in the era of new CZT cameras
No full text
Evaluation of the arrhythmic risk in the 21st century: is multi-tracer nuclear imaging the answer?
No full textDynamic ultrafast CZT imaging: Time for a paradigm change in myocardial perfusion imaging
No full textEvaluation of dyssynchrony with nuclear cardiac imaging: New evidence for an old parameter
No full textDetection of ischemia with early myocardial perfusion imaging: You see more if you watch before
No full textCoronary atherosclerosis and quantitative myocardial perfusion: A relationship beyond stenosis
No full text
- …
